Caribou Biosciences Q1 2025 10-Q Filing

Ticker: CRBU · Form: 10-Q · Filed: May 8, 2025 · CIK: 1619856

Caribou Biosciences, INC. 10-Q Filing Summary
FieldDetail
CompanyCaribou Biosciences, INC. (CRBU)
Form Type10-Q
Filed DateMay 8, 2025
Risk Levelmedium
Sentimentneutral

Sentiment: neutral

Topics: 10-Q, biotechnology, financials

TL;DR

Caribou Bio Q1 2025 10-Q filed. Financials and operations update.

AI Summary

Caribou Biosciences, Inc. filed its quarterly report for the period ending March 31, 2025. The company, focused on biological products, reported its financial status and operational highlights. Key financial data and related party transactions are detailed within this filing.

Why It Matters

This filing provides investors with an update on Caribou Biosciences' financial health and operational progress for the first quarter of 2025, crucial for assessing the company's trajectory in the biotechnology sector.

Risk Assessment

Risk Level: medium — Biotechnology companies often face inherent risks due to the long development cycles, regulatory hurdles, and competitive landscape.

Key Numbers

Key Players & Entities

FAQ

What is the primary business of Caribou Biosciences, Inc.?

Caribou Biosciences, Inc. is primarily involved in the development of biological products, specifically in the area of biological products (no diagnostic substances).

For what period is this 10-Q filing reporting?

This 10-Q filing reports for the period ending March 31, 2025.

When was this 10-Q filing submitted to the SEC?

This 10-Q filing was submitted to the SEC on May 8, 2025.

What is the company's SEC File Number?

The SEC File Number for Caribou Biosciences, Inc. is 001-40631.

Where is Caribou Biosciences, Inc. located?

Caribou Biosciences, Inc. is located at 2929 7th Street, Suite 105, Berkeley, CA 94710.

Filing Details

This Form 10-Q (Form 10-Q) was filed with the SEC on May 8, 2025 regarding Caribou Biosciences, Inc. (CRBU).

View full filing on EDGAR

View Full Filing

View this 10-Q filing on SEC EDGAR

View on Read The Filing